Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acne fulminans
adverse drug reaction
amphiphysin antibodies
anorexia
anti HMGCR antibody
anti Hu antibody
anti Ku antibody
anti MAG antibodies
anti Ri antibody
anti Yo antibody
anticholinesterase
antisynthetase syndrome
arbovirus
areflexia
arthralgia
arthritis
aspartate aminotransferase
ataxia
atypical
autoantibodies
autoimmune disease
autonomic neuropathy
biologic markers
brachial neuritis
brain biopsy
brain natriuretic peptide
carcinoma
carcinoma of breast
carcinoma of lung
carcinoma of ovary
cerebellar degeneration
cerebellar lesion
cerebellum
cerebrospinal fluid, elevated protein of
cerebrospinal fluid, oligoclonal IgG in
cerebrovascular accident
chemical weapons
chemotherapy, CNS treatment and complications with
chronic fatigue syndrome
Clinical Pathologic Conference(C.P.C.)
cognition
collagen vascular disease
collapsin response mediator protein 5 IgG
coma
complications
concentration, impaired
confusion
contactin associated protein like 2 antibodies
cranial nerve palsies
creatine phosphokinase(CPK)elevated
cytokines
DEET
demyelinating disease
dermatomyositis
disability, neurological
distal muscle weakness
dropped head syndrome
drug induced neurologic disorders
duvalumab
dysphagia
dyspnea
electromyogram
ELISA
encephalitis
encephalitis, autoimmune
encephalitis, brainstem
encephalitis, paraneoplastic
encephalomyelitis
encephalopathy
enzyme, muscle disease
enzyme, serum
facial nerve palsy
falling
fatigue
fever
fibrillations
flaccid paralysis
gait disorder
gammaglobulin therapy, intravenous
Guillain Barre syndrome
Gulf War syndrome
headache
herpes virus
herpes virus infection
hip pain
HMGcoA reductase inhibitors
Hodgkin's disease
Hodgkin's disease, neurologic involvement with
human herpesvirus 6
iatrogenic neurologic disorders
immune checkpoint inhibitors
immune-related adverse events
immunologic disease
immunology and the nervous system
immunosuppression
immunosuppressive agents
immunotherapy
inclusion bodies, intracytopasmic
inclusion bodies, intranuclear
inclusion body myositis
insect repellent
insecticides
ipilimumab
leucine rich glioma inactivated 1 antibodies
leukocytosis
limb-girdle weakness
limbic encephalitis
liver function enzymes
lymphadenopathy
malignancy screen
malignancy, occult
melanoma, malignant
meningitis
meningitis, neutrophilic
meningoencephalitis
mental status, abnormal
mestinon
methotrexate
misdiagnosis
mortality
mosquito
MRI
MRI, abnormal
MRI, disappearing lesion on
MRI, muscle
MRI, sulcal hyperintensity
multiple sclerosis
muscle atrophy, progressive
muscle biopsy
muscle pain
muscle weakness
muscle weakness, pattern
muscular dystrophy, facioscapulohumeral
myasthenia gravis
myasthenia gravis, etiology of
myasthenia gravis, paraneoplastic
myasthenic syndrome
myocarditis
myopathy
myopathy, autoimmune
myopathy, carcinomatous
myopathy, drug-induced
myopathy, inflammatory
myopathy, inflammatory, classification
myopathy, necrotizing
myopathy, necrotizing, autoimmune
myopathy, necrotizing, immune-mediated
myopathy, steroid induced
myopathy, steroid responsive
myopathy, toxic
myositis
myositis, overlap
nerve agents
nerve conduction studies
neurologic complications of, systemic cancer
neurologic disease
neurologic disease, diagnoses of
neurologic disease, multifocal
neurologic signs
neurologic symptoms
neuromuscular junction
neuromuscular junction, abnormality of
neuronal cell surface antigen
neuronopathy, sensory
neuropathy
neuropathy, iatrogenic
neuropathy, paraneoplastic
neuropathy, toxic
neurotoxic
neurotoxin
nivolumab
NMDA antagonists
ocular motility, disorders of
onconeural antibodies
ophthalmoplegia
opsoclonus-myoclonus syndrome
pain
paralysis, acute
paralysis, acute areflexic
paraneoplastic cerebellar degeneration
pathology
pembrolizumab
peripheral nerve, lesion of
plasmapheresis
pleocytosis of cerebrospinal fluid
POEMS syndrome
poison, organophosphate
polymerase chain reaction, false negative
polymyositis
polyneuropathy
polyneuropathy, chronic inflammatory demyelinating
positive sharp waves
postviral fatigue syndrome
prognosis
progressive neurologic disorder
ptosis
Purkinje cell
rapidly progressing neurologic illness
rash
Red flags
remote effect of cancer on the nervous system
respiratory failure
respiratory tract infection
retinopathy
reversible neurologic disorder
review article
rhabdomyolysis
risk factors
safety
screening
seizure
serologic testing
serum alanine aminotransferase
sex reassignment surgery
skin, lesions in neurologic disorders
splinter hemorrhages
statin therapy
statin therapy, discontinuation
steroid
steroid therapy, CNS treatment and complications with
Still's disease
systemic illness
temporal lobe, lesion
temporal lobe, lesion, bilateral
thalamus, infarction, bilateral
thalamus, lesion of
thymoma
transgender
transient neurologic deficit
treatment of neurologic disorder
unconsciousness
urine, dark
vaccination, neurologic complications with
viral infection
viral infection, CNS
visual loss
walking, difficulty with
war
weakness
weakness, generalized
weakness, progressive
weakness, proximal
weight loss
West Nile fever
wheelchair
workup
Showing articles 1650 to 1700 of 2250 << Previous Next >>

The Efficacy of Azathiorpine in Relapsing-Remitting Multiple Sclerosis
Neurol 41:20-25, Goodkin,D.E.,et al, 1991

The Canadian Coop Trial of Cyclophosphamide and Plasma Exchange in Progr MS
The Canadian Coop MS Study Group, Lancet 337:441-4461991., , 1991

Depletion of Muscle Mitochondrial DNA in AIDS Patients with Zidovudine-Induced Myopathy
Lancet 337:508-510, Arnaudo,E.,et al, 1991

Myopathy with Human Immunodeficiency Virus Type I (HIV-1) Infection:HIV-1 or Zidovudine?
Ann Int Med 113:492-493, Till,M.&MacDonell,K., 1990

Human Immunodeficiency Virus Assoc Myopathy:Immunocytochemical Ident of an HIV Antigen (gp41) in Muscle Macrophages
Ann Neurol 28:579-582, Chad,D.A.,et al, 1990

OKT3 Encephalopathy
Ann Neurol 28:837-838, Coleman,A.E.&Norman,D.J., 1990

A Clinical Triad to Diagnose Paraneoplastic Retinopathy
Ann Neurol 28:162-167, Jacobson,D.M.,et al, 1990

Cerebral Cortex and Brainstem Involvement in Marinesco-Sjogren Syndrome
Ann Neurol 27:448-449, Katafuchi,Y.,et al, 1990

Relative Increase of T Cells Expressing Gamma/Delta Rather than Alpha/Beta Receptor in Ataxia-Telangietasia
NEJM 322:73-76, 1241990., Carbonari,M.,et al, 1990

Clinicopath Conf
Eosinophilic Fasciitis, Case Study 4-1990, NEJM 322:252-261, 93190., , 1990

Development of Diffuse Fasciitis with Eosinophilia During L-Tryptophan Treatment:Elevated Type I Collagen Gene
Ann Int Med 112:344-351, Varga,J.,et al, 1990

Clinicopath Conf
Familial Visceral Myopathy (Oculogastrointestinal Muscular Dystrophy) , Case 12-1990, NEJM 322:829-8, 1, 19, 1990

Benefit of Intravenously Administered Immune Serum Globulin in Patients with Guillain-Barre Syndrome
J Pediatr 116:141-144, Shahar,E.,et al, 1990

A Controlled Trial of Azathioprine in Behcet's Syndrome
NEJM 322:281-285, Yazici,H.,et al, 1990

Night-Time Nasal Ventilation in Neuromuscular Disease
Lancet 335:579-582, Heckmatt,J.Z.,et al, 1990

Use of Immunosuppressive Agents in the Treatment of Severe Ocular and Vascular Manifestations of Cogan's Syndrome
Am J Med 88:296-301, Allen,N.B.,et al, 1990

High-Dose Intravenous Immunoglobulin in the Treatment of Demyelinating Neuropathy with Monoclonal Gammopathy
Neurol 40:212-214, 327-3281990., Cook,D.,et al, 1990

High-Dose Intravenous Immunoglobulin Treatment in Chronic Imflammatory Demyelinating Polyneuropathy
Neurol 40:209-212, 327-3281990., vanDoorn,P.A.,et al, 1990

Scleroderma, fasciitis, and Eosinophilia Associated with the Ingestion of Tryptophan
NEJM 322:874-881, 9261990., Silver,R.M.,et al, 1990

Association of the Eosinophilia-Myalgia Syndrome with the Ingestion of Tryptophan
NEJM 322:869-873, 9261990., Hertzman,P.A.,et al, 1990

Genetic Testing for Huntington's Disease
BMJ 300:1089-1090, Harper,P.,et al, 1990

Efficacy & Toxicity of Cyclosporine in Chronic Progressive Multiple Sclerosis:A Randomized Clinical Trial
M. S. Study Group, Ann Neurol 27:591-605, 5890., , 1990

Cyclosporine-Related Central Nervous System Toxicity in Cardiac Transplantation
NEJM 323:420-421, Hughes,R.L., 1990

Neurotoxicity After Treatment with Muromonab-CD3
NEJM 323:487-488, Richards,J.M.,et al, 1990

Autoantibodies to Gaba-Ergic Neurons & Pancreatic Beta Cells in Stiff-Man Syndrome
NEJM 322:1555-1560, Solimena,M.,et al, 1990

Mitochondrial Myopathy Caused by Long-Term Ziduvudine Therapy
NEJM 322:1098-1105, Dalakas,M.C.,et al, 1990

Intravenous Immune Globulin and Acute Aseptic Meningitis
NEJM 323:614-615, Van-Daele,M.C.,et al, 1990

Clinicopath Conf
Acute Febrile Neutrophilic Dermatosis (Sweet's Syndrome) , Case 30-1990, NEJM 323:254-2630., , 1990

Polyneuropathy, Ophthalmoplegia, Leukoencephalopathy, and Intestinal Pseudo-Obstruction:POLIP Syndrome
Ann Neurol 28:349-360, Simon,L.T.,et al, 1990

Progressive Rubella Panencephalitis
In Handbk of Clin Neurol, Vinken & Bruyn, Ed, N Holland Publ Co, 56:405-416, Wolinsky,J.S., 1990

Acute CNS Infection by Trypanosoma Cruzi (Chagas'Disease) in Immunosuppressed Patients
Neurol 40:850-851, Leiguarda,R.,et al, 1990

AIDS and Chagas'Disease with Central Nervous System Tumor-Like Lesion, Brief Clinical Observation
Am J Med 88:693-694, Castillo,M.D.,et al, 1990

Attitudes of Mothers to Neonatal Screening for Duchenne Muscular Dystrophy
BMJ 300:1112, Smith,R.A.,et al, 1990

Molecular Genetics of Duchenne and Becker Muscular Dystrophy
J Pediatr 117:1-15, Darras,B.T., 1990

Presymptomatic and Prenatal Diagnosis in Myotonic Dystrophy by Genetic Linkage Studies
Neurol 40:671-676, Speer,M.C.,et al, 1990

Fluctuating MR Images with Mitochondrial Encephalopathy, Lactic Acidosis, Stroke-Like Syndrome (MELAS)
Neuroradiology 32:77, Abe,K.,et al, 1990

Mitochondrial Myopathy with a Defect of Mitochondrial-Protein Transport
NEJM 323:37-42, Schapira,A.H.V.,et al, 1990

Mitochondrial Encephalomyopathy (MELAS) with Mental Disorder, CT, MRI and SPECT Findings
Neuroradiology 32:74-76, Suzuki,T.,et al, 1990

Myopathy and Rhabdomyolysis Associated with Lovastatin-Gemfibrozil Combination Therapy
JAMA 264:71-75, Pierce,L.R.,et al, 1990

Peripheral Neuropathy in the Eosinophilia-Myalgia Syndrome Associated with L-Tryptophan Ingestion
Neurol 40 1035-1040, Smith,B.E.&Dyck,P.J., 1990

The Clinical Spectrum of the Eosinophilia-Myalgia Syndrome Associated with L-Tryptophan Ingestion
Ann Int Med 113:124-134, Martin,R.W.,et al, 1990

L-Tryptophan-Associated Eosinophilic Perimyositis, Neuritis, and Fasciitis
Medicine 69:187-199, Kaufman,L.D.,et al, 1990

Autosomal Dominant Cramping Disease
Arch Neurol 47:810-812, Ricker,K.&Moxley,R.T., 1990

Congenital Inflammatory Myopathy
Neurol 40:1111-1114, Shevell,M.,et al, 1990

Lower Motor Neuron Disease in a Patient with Autoantibodies Against Gangliosides GM1 and GD1b:Improvement with Immunotherapy
Neurol 40:842-844, Shy,M.E.,et al, 1990

Progressive Myopathy in Hyperkalemic Periodic Paralysis
Arch Neurol 47:1013-1017, Bradkey,W.G.,et al, 1990

Eosinophilia-Myalgia Syndrome (L-Tryptophan-Associated Neuromyopathy)
Neurol 40:1793-1796, Turi,G.K.,et al, 1990

L-Tryptophan-Induced Eosinophila-Myalgia Syndrome and Myopathy
Neurol 40:1629-1630, Sagman,D.L.&Melamed,J.C., 1990

New Muscle Power Test in Neuromuscular Disease
Am J Dis Child 144:1083-1087, Tirosh,E.,et al, 1990

Neurosarcoidosis:Signs, Course and Treatment in 35 Confirmed Cases
Medicine 69:261-276, Chapelon,C.,et al, 1990



Showing articles 1650 to 1700 of 2250 << Previous Next >>